Company Description
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.
Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production.
It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits.
The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012.
BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
| Country | United States |
| Founded | 1984 |
| IPO Date | Nov 13, 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 157 |
| CEO | John R. Beaver |
Contact Details
Address: 27042 Towne Centre Drive, Suite 270 Foothill Ranch, California 92610 United States | |
| Phone | 949-361-1200 |
| Website | biolase.com |
Stock Details
| Ticker Symbol | BIOL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000811240 |
| CUSIP Number | 090911207 |
| ISIN Number | US0909117022 |
| Employer ID | 87-0442441 |
| SIC Code | 3843 |
Key Executives
| Name | Position |
|---|---|
| John R. Beaver | President, Chief Executive Officer and Director |
| Jennifer Bright | Chief Financial Officer |
| Steven Sandor | Chief Operating Officer |
| Michael C. Carroll | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 19, 2024 | POS AM | Post-Effective amendments for registration statement |
| Apr 19, 2024 | 8-K | Current Report |
| Apr 11, 2024 | POS AM | Post-Effective amendments for registration statement |
| Apr 4, 2024 | 424B3 | Prospectus |
| Apr 2, 2024 | EFFECT | Notice of Effectiveness |
| Mar 27, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Mar 22, 2024 | ARS | Filing |
| Mar 22, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 22, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 21, 2024 | 10-K | Annual Report |